RN
Rein Therapeutics Inc. (RNTX)
NASDAQ·Healthcare·Medical - Pharmaceuticals
$1.46
-2.01%
Mkt Cap $31.54M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
+311.0%
Consensus $6.00 vs current $1.46